Testing an inhaled drug for COPD symptoms
Part of Lungs & breathing clinical trials.
This trial tests a new inhaled drug, HSK39004, to see if it safely improves breathing and quality of life in people with moderate to severe COPD. You may join if you are between 40 and 80, have a COPD diagnosis with certain lung function results, and have at least some shortness of breath with daily activities.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 80 years old.
- You have been diagnosed with COPD and your lung function tests show moderate to severe airflow blockage (FEV1 between 30% and 80% of normal, and FEV1/FVC less than 0.7).
- You often feel short of breath during daily activities (mMRC breathlessness score of 2 or higher).
- You have not had a COPD flare-up requiring emergency treatment or hospitalization in the past 12 weeks.
- You have not had a respiratory infection like a cold or pneumonia in the past 6 weeks.
- You do not have other serious lung diseases (like asthma or tuberculosis), heart problems, or cancer that is not cured.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new inhaled medication called HSK39004 can help people with COPD breathe better and reduce shortness of breath. You'll receive either the medication or a placebo (inactive powder) and be monitored for safety and effectiveness.
This trial tests a new medicine, Hemay005, in adults with moderate to severe COPD who also have a chronic cough with mucus. It looks at how the drug affects certain markers in the body related to the disease.
This study tests whether a new inhaled medication called HSK39004 is safe and effective for people with moderate to severe COPD (a lung disease that makes breathing difficult). You would use this medicine regularly over a long period and have your lung function and symptoms checked.
This study tests an inhaled medication called RB042 in healthy adults, healthy smokers, and people with COPD. It aims to see how the drug works in the body and whether it is safe, which could help in developing a new treatment for COPD.
This study tests an experimental drug called JKN2403 for people with moderate to severe COPD. It aims to see if the drug can reduce flare-ups and improve breathing compared to a placebo (a dummy pill).
This trial tests an experimental tablet called XH-S004 for people with moderate-to-severe COPD. It looks at how safe the drug is, how the body processes it, and if it helps symptoms.
Hear when a new COPD (Chronic Obstructive Pulmonary Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.